Pneumonia & Diarrhea



Executive Summary | Global Evaluating Burden Progress of Pneumonia in the 15 and Highest Diarrhea Burden in Children Countries

Evaluating Progress in the 15 Highest Burden Countries

This 2015 Pneumonia and Diarrhea Progress Report

evaluates the progress of the 15 countries with the

greatest burden of under-five pneumonia and diarrhea

deaths in implementing high-impact interventions

outlined in the Global Action Plan for the Prevention

and Control of Pneumonia and Diarrhea (GAPPD) 3 ,

where data are available, and evaluates the need to

accelerate the implementation of select interventions

and assure sustainability of that progress.

The coverage targets for interventions included

in this report are:

90% for vaccinations

Pertussis vaccine

Measles vaccine

Haemophilus influenzae type b (Hib) vaccine

Pneumococcal conjugate vaccine

Collectively, these ten interventions

are evaluated and summarized into an

overall GAPPD score, developed by the

International Vaccine Access Center

(IVAC) at the Johns Hopkins Bloomberg

School of Public Health. These GAPPD

scores are used to assess and compare

progress over time in the highest-burden

countries with the greatest number

of pneumonia and diarrhea deaths in

children under the age of five years.

GAPPD scores are a calculated average

of countries’ coverage levels for the

ten GAPPD indicators, using the most

recent data available.

Rotavirus vaccine

90% for pneumonia and diarrhea treatments

Treatment of children with suspected pneumonia by a

health care provider

Antibiotic use in children with suspected pneumonia

Oral rehydration salts (ORS) for children with diarrhea

Zinc supplements for children with diarrhea

50% for exclusive breastfeeding

Exclusive breastfeeding for the first 6 months of life

Pneumonia & Diarrhea Progress Report 2015


Similar magazines